Latest News

Experts on obesity including representatives of the Obesity Society and the American Society for Metabolic and Bariatric Surgery, to name but a few organisations involved, met with an FDA (Food and Drug Administration) spokesperson on Tuesday to discuss the future of the weight loss drug market as p...

Very disappointing news for the millions of obese Americans as the FDA rejects weight loss drug Contrave, insisting on an extensive cardiovascular study...

Vivus’ shares have dropped since last Wednesday’s meeting with the FDA...

Finally, a glimmer of hope for those seeking weight loss pills...

Orexigen’s weight loss drug Contrave, is next up on the chopping block but it might experience more mercy than the recent spurt of weight loss treatments that were refused approval this year...